Literature DB >> 16000080

Tissue microarrays: bridging the gap between research and the clinic.

Till Braunschweig1, Joon-Yong Chung, Stephen M Hewitt.   

Abstract

Tissue microarrays are a high-throughput method for the investigation of biomarkers in multiple tissue specimens at once. This technique allows for the analysis of up to 500 tissue samples in a single experiment using immunohistochemistry and in situ hybridization. Recently, cell lines and xenografts have been reduced to a tissue microarray format and are being applied to preclinical drug development. In clinical research, tissue microarrays are applied at multiple levels: comprehensive analysis of samples in the context of a clinical trial or across a population. Tissue microarrays play a central role in translational research, facilitating the discovery of molecules that have potential roles in the diagnosis, prognosis and prediction of response to therapy.

Mesh:

Substances:

Year:  2005        PMID: 16000080     DOI: 10.1586/14789450.2.3.325

Source DB:  PubMed          Journal:  Expert Rev Proteomics        ISSN: 1478-9450            Impact factor:   3.940


  19 in total

1.  Observer variability in the interpretation of HER2/neu immunohistochemical expression with unaided and computer-aided digital microscopy.

Authors:  Marios A Gavrielides; Brandon D Gallas; Petra Lenz; Aldo Badano; Stephen M Hewitt
Journal:  Arch Pathol Lab Med       Date:  2011-02       Impact factor: 5.534

2.  A novel tissue array technique for high-throughput tissue microarray analysis -- microarray groups.

Authors:  Hui-Yong Jiang; Xue-Feng Zhang; Li Liu; Hui-Ling Li; Tong Zhao
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-05-21       Impact factor: 2.416

3.  Association of tumor-associated trypsin inhibitor (TATI) expression with molecular markers, pathologic features and clinical outcomes of urothelial carcinoma of the urinary bladder.

Authors:  Oliver Patschan; Shahrokh F Shariat; Daher C Chade; Pierre I Karakiewicz; Raheela Ashfaq; Yair Lotan; Kristina Hotakainen; Ulf-Håkan Stenman; Anders Bjartell
Journal:  World J Urol       Date:  2011-07-08       Impact factor: 4.226

4.  A 'waterfall' transfer-based workflow for improved quality of tissue microarray construction and processing in breast cancer research.

Authors:  M Oberländer; H Alkemade; S Bünger; F Ernst; C Thorns; T Braunschweig; J K Habermann
Journal:  Pathol Oncol Res       Date:  2014-03-07       Impact factor: 3.201

5.  Comparison of immunohistochemistry and mRNA in situ hybridization in detecting thyroid transcription factor-1 expression in non-small cell lung carcinomas tissue.

Authors:  Huiyong Jiang; Xiaoyan Bai; Fanjun Meng; Xuefeng Zhang
Journal:  Oncol Lett       Date:  2015-09-29       Impact factor: 2.967

6.  Tissue microarrays as a tool in the discovery and validation of predictive biomarkers.

Authors:  Stephen M Hewitt
Journal:  Methods Mol Biol       Date:  2012

7.  HDAC2 and TXNL1 distinguish aneuploid from diploid colorectal cancers.

Authors:  Timo Gemoll; Uwe J Roblick; Silke Szymczak; Till Braunschweig; Susanne Becker; Bernd-Wolfgang Igl; Hans-Peter Bruch; Andreas Ziegler; Ulf Hellman; Michael J Difilippantonio; Thomas Ried; Hans Jörnvall; Gert Auer; Jens K Habermann
Journal:  Cell Mol Life Sci       Date:  2011-02-03       Impact factor: 9.261

Review 8.  Tissue microarrays as a tool in the discovery and validation of tumor markers.

Authors:  Stephen M Hewitt
Journal:  Methods Mol Biol       Date:  2009

9.  Polyisoprenylated methylated protein methyl esterase overexpression and hyperactivity promotes lung cancer progression.

Authors:  Felix Amissah; Randolph Duverna; Byron J Aguilar; Rosemary A Poku; Gebre-Egziabher Kiros; Nazarius S Lamango
Journal:  Am J Cancer Res       Date:  2014-03-01       Impact factor: 6.166

10.  Automated quantitative assessment of HER-2/neu immunohistochemical expression in breast cancer.

Authors:  Hela Masmoudi; Stephen M Hewitt; Nicholas Petrick; Kyle J Myers; Marios A Gavrielides
Journal:  IEEE Trans Med Imaging       Date:  2009-01-19       Impact factor: 10.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.